WPI 3154 (Modafinil 100 mg)

Pill imprint WPI 3154 has been identified as Modafinil 100 mg.

Modafinil is used in the treatment of chronic fatigue syndrome; adhd; shift work sleep disorder; narcolepsy; obstructive sleep apnea/hypopnea syndrome (and more), and belongs to the drug class CNS stimulants. Risk cannot be ruled out during pregnancy. Modafinil 100 mg is classified as a Schedule 4 controlled substance under the Controlled Substance Act (CSA).

Modafinil

Imprint:

WPI 3154

Strength:

100 mg

Color:

White

Shape:

Capsule-shape

Availability:

Prescription only

Drug Class:

CNS stimulants

Pregnancy Category:

C - Risk cannot be ruled out

CSA Schedule:

4 - Some potential for abuse

Manufacturer:

Watson Laboratories, Inc.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.